{
  "pmid": "14974877",
  "uid": "14974877",
  "title": "The NICE reference case requirement: more pain for what, if any, gain?",
  "abstract": "",
  "authors": [
    {
      "last_name": "Gafni",
      "fore_name": "Amiram",
      "initials": "A",
      "name": "Amiram Gafni",
      "affiliations": []
    },
    {
      "last_name": "Birch",
      "fore_name": "Stephen",
      "initials": "S",
      "name": "Stephen Birch",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "PharmacoEconomics",
    "iso_abbreviation": "Pharmacoeconomics",
    "issn": "1170-7690",
    "issn_type": "Print",
    "volume": "22",
    "issue": "4",
    "pub_year": "2004"
  },
  "start_page": "271",
  "end_page": "273",
  "pages": "271-3",
  "language": "eng",
  "publication_types": [
    "Comment",
    "Letter"
  ],
  "keywords": [
    "Delivery of Health Care",
    "Drug Industry",
    "England",
    "Quality-Adjusted Life Years",
    "Technology Assessment, Biomedical",
    "Wales"
  ],
  "article_ids": {
    "pubmed": "14974877",
    "doi": "10.2165/00019053-200422040-00006",
    "pii": "2246"
  },
  "doi": "10.2165/00019053-200422040-00006",
  "dates": {
    "completed": "2004-05-04",
    "revised": "2018-11-13"
  },
  "chemicals": [],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:21:44.837456",
    "pmid": "14974877"
  }
}